GLP-1 medications for weight loss are becoming so common that most of us know someone taking oneor are taking one ourselves
People with uncontrolled high blood pressure, seizure disorders, certain eating disorders, chronic opioid use, or who are taking other bupropion-containing medications to treat depression may not be able to take it
This produces very high, stage-specific rates: surveys of biotech practitioners using standard NPV have found average discount rates of 40.1% for early-stage projects, 26.7% for mid-stage, and 19.5% for late-stage
Many people are turning to semaglutide injections as a modern, effective tool for achieving significant weight loss results
Meet our doctors Last reviewed: 16 Oct 2025 Sources Wegovy SmPC, emc [accessed 14 October 2025] Xenical SmPC, emc [accessed 14 October 2025] Orlistat, patient.info [accessed 14 October 2025] Xenical Patient Information Leaflet, emc [accessed 14 October 2025] Wegovy Patient Information Leaflet, emc [accessed 14 October 2025]